InvestSMART

Pro Medicus Limited (ASX:PME)

ALERT: Price-sensitive ASX Announcement for PME
Current share price for PME : $157.450 -12.02 (-7.09%)+
Announcement
Release
12 Feb 2026 9:09AM
Price at Release
$169.470
Full Release
download
Summary
The document is an Appendix 4D report for Pro Medicus Limited, detailing the company's financial performance for the half-year ended 31 December 2023, as required under the Australian Securities Exchange (ASX) listing rules. The report highlights a significant increase in revenue and profit, driven by strong sales and operational efficiency. The company emphasizes its strategic focus on expanding its global market presence and continuous investment in research and development to enhance its product offerings. The financial statements include detailed accounts of revenue streams, expenses, and cash flow, underscoring the company's robust financial health. The document concludes with a positive outlook for the remainder of the financial year, supported by a strong order book and strategic partnerships.
Key Points
  • Pro Medicus Limited reports significant revenue and profit growth.
  • Strong sales and operational efficiency drive financial performance.
  • Focus on global market expansion and R&D investment.
  • Robust financial health highlighted in detailed financial statements.
  • Positive outlook for the remainder of the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.